An Observational Study of Individuals With Isolated Dystonia
Condition(s) studied
Study summary
This is an observational study in individuals with isolated (or primary) dystonia that involves more than one body region. The purpose of the study is to collect detailed information to help your physician and other researchers understand how dystonia impacts your and other patients' lives and how the disease changes over time. The study may also help researchers better understand the clinical scales that are commonly used to evaluate dystonia symptoms and how they affect various areas of life such as well-being, pain, relationships and social interactions, and progress over time. Because this is an observational study, you will not receive any interventional treatment in the study.
Eligibility
Primary outcome measure(s)
- Burke-Fahn-Marsden (BFM) Dystonia Rating Scale — From start of treatment through 4 months
The BFM was developed to quantitatively assess primary dystonias (Burke 1985). It is composed of 2 subscales: a movement subscale, based on the clinician's evaluation of the patient in nine body areas, and a disability subscale, based on the participant's report of disability in activities of daily living.
Trial sites (29)
| Facility | City | Region | Status |
|---|---|---|---|
| Vima Site #004 | Scottsdale | Arizona | |
| Vima Site #028 | Sun City | Arizona | |
| Vima Site #010 | Aliso Viejo | California | |
| Vima Site #030 | Los Angeles | California | |
| Vima Site #022 | Palo Alto | California | |
| Vima Site #019 | Englewood | Colorado | |
| Vima Site #003 | Boca Raton | Florida | |
| Vima Site #009 | Gainesville | Florida | |
| Vima Site #008 | Miami | Florida | |
| Vima Site #031 | Orlando | Florida | |
| Vima Site #005 | Atlanta | Georgia | |
| Vima Site #027 | Chicago | Illinois | |
| Vima Site #007 | Olney | Maryland | |
| Vima Site #002 | Farmington Hills | Michigan | |
| Vima Site #014 | Albuquerque | New Mexico | |
| Vima Site #017 | Commack | New York | |
| Vima Site #018 | New York | New York | |
| Vima Site #024 | New York | New York | |
| Vima Site #029 | Portland | Oregon | |
| Vima Site #020 | Philadelphia | Pennsylvania | |
| Vima Site #021 | Charleston | South Carolina | |
| Vima Site #016 | Memphis | Tennessee | |
| Vima Site #006 | Nashville | Tennessee | |
| Vima Site #025 | Dallas | Texas | |
| Vima Site #026 | Georgetown | Texas | |
| Vima Site #012 | Houston | Texas | |
| Vima Site #011 | Richmond | Virginia | |
| Vima Site #023 | Kirkland | Washington | |
| Vima Site #015 | Spokane | Washington |
More Vima Therapeutics trials in the USA
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07111663 on ClinicalTrials.gov ↗ ← All trials in the USA